KR20020047245A - 면역요법에 사용하기 위한 수정 펩티드 및 펩티드모방체 - Google Patents

면역요법에 사용하기 위한 수정 펩티드 및 펩티드모방체 Download PDF

Info

Publication number
KR20020047245A
KR20020047245A KR1020027004940A KR20027004940A KR20020047245A KR 20020047245 A KR20020047245 A KR 20020047245A KR 1020027004940 A KR1020027004940 A KR 1020027004940A KR 20027004940 A KR20027004940 A KR 20027004940A KR 20020047245 A KR20020047245 A KR 20020047245A
Authority
KR
South Korea
Prior art keywords
ser
gly
ala
thr
phe
Prior art date
Application number
KR1020027004940A
Other languages
English (en)
Korean (ko)
Inventor
반스타베렌카테리나조안나
티머르스코르넬리스마리우스
갈렌반필리푸스조한네스마리에
크네그텔르날두스마르셀루스알폰수스
부츠안나마리아헬레나
밀텐부르그안드레아스마르티누스마리아
Original Assignee
에프.지.엠. 헤르만스 ; 이.에이치. 리링크
악조 노벨 엔.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프.지.엠. 헤르만스 ; 이.에이치. 리링크, 악조 노벨 엔.브이. filed Critical 에프.지.엠. 헤르만스 ; 이.에이치. 리링크
Publication of KR20020047245A publication Critical patent/KR20020047245A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020027004940A 1999-10-18 2000-10-12 면역요법에 사용하기 위한 수정 펩티드 및 펩티드모방체 KR20020047245A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99203427.2 1999-10-18
EP99203427 1999-10-18
PCT/EP2000/010230 WO2001029081A1 (en) 1999-10-18 2000-10-12 Modified peptides and peptidomimetics for use in immunotherapy

Publications (1)

Publication Number Publication Date
KR20020047245A true KR20020047245A (ko) 2002-06-21

Family

ID=8240756

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027004940A KR20020047245A (ko) 1999-10-18 2000-10-12 면역요법에 사용하기 위한 수정 펩티드 및 펩티드모방체

Country Status (23)

Country Link
EP (1) EP1226167A1 (cs)
JP (1) JP2003512388A (cs)
KR (1) KR20020047245A (cs)
CN (1) CN1379786A (cs)
AR (1) AR026068A1 (cs)
AU (1) AU780238B2 (cs)
BR (1) BR0014803A (cs)
CA (1) CA2386398A1 (cs)
CO (1) CO5271650A1 (cs)
CZ (1) CZ20021356A3 (cs)
HK (1) HK1046693A1 (cs)
HU (1) HUP0203504A3 (cs)
IL (1) IL148778A0 (cs)
MX (1) MXPA02003520A (cs)
NO (1) NO20021763L (cs)
NZ (1) NZ518256A (cs)
PE (1) PE20010692A1 (cs)
PL (1) PL354590A1 (cs)
RU (1) RU2002113107A (cs)
SK (1) SK6842002A3 (cs)
TR (1) TR200201036T2 (cs)
WO (1) WO2001029081A1 (cs)
ZA (1) ZA200202577B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002951212A0 (en) * 2002-09-04 2002-09-19 Monash University A method of modulating cellular activity and molecules for use therein
AU2007235305A1 (en) * 2006-04-06 2007-10-18 Purdue Research Foundation Derivatization-enhanced analysis of amino acids and peptides
US20100278745A1 (en) * 2006-12-21 2010-11-04 Norbert Lange Compounds for fluorescence imaging
CA2740028A1 (en) 2008-01-23 2009-07-30 Herlev Hospital Ykl-40 as a general marker for non-specific disease
CA2737292A1 (en) 2008-09-15 2010-03-18 Herlev Hospital Ykl-40 as a marker for gastrointestinal cancers
WO2016073949A1 (en) 2014-11-07 2016-05-12 Kineta Three, Llp Modifications and uses of conotoxin peptides
EP3466963A1 (en) * 2017-10-05 2019-04-10 Suigeneris Farmacosmetics, S.L. Anticancer peptides and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
TW575583B (en) * 1996-04-24 2004-02-11 Akzo Nobel Nv Novel peptides suitable for use in antigen specific immunosuppressive therapy
JP2000512277A (ja) * 1996-06-07 2000-09-19 ゼネカ・リミテッド ペプチド誘導体
IL122233A (en) * 1996-12-06 2001-04-30 Akzo Nobel Nv Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them

Also Published As

Publication number Publication date
NZ518256A (en) 2004-01-30
CZ20021356A3 (cs) 2002-07-17
NO20021763D0 (no) 2002-04-15
RU2002113107A (ru) 2004-01-10
CN1379786A (zh) 2002-11-13
BR0014803A (pt) 2002-06-11
WO2001029081A1 (en) 2001-04-26
HUP0203504A3 (en) 2005-03-29
PE20010692A1 (es) 2001-07-06
MXPA02003520A (es) 2002-08-20
SK6842002A3 (en) 2002-09-10
AR026068A1 (es) 2002-12-26
TR200201036T2 (tr) 2002-08-21
NO20021763L (no) 2002-04-15
ZA200202577B (en) 2003-09-23
JP2003512388A (ja) 2003-04-02
EP1226167A1 (en) 2002-07-31
AU1139601A (en) 2001-04-30
IL148778A0 (en) 2002-09-12
HUP0203504A2 (hu) 2003-04-28
HK1046693A1 (zh) 2003-01-24
CA2386398A1 (en) 2001-04-26
CO5271650A1 (es) 2003-04-30
AU780238B2 (en) 2005-03-10
PL354590A1 (en) 2004-01-26

Similar Documents

Publication Publication Date Title
AU704502B2 (en) Non-dendritic backbone peptide carrier
JP2003521448A (ja) 合成ペプチドおよび自己免疫疾患治療のための使用方法
IE912701A1 (en) Novel immunosuppressant peptides
SK166798A3 (en) Peptide derivatives, process for their preparation, pharmaceutical composition them containing, and their use
US6821517B1 (en) Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
WO1986004334A1 (en) Immunoregulatory peptides
US20070161545A1 (en) Triple polypeptide complexes
HU218027B (hu) Autoantigénekből származó peptidek autoimmun betegségek immunterápiás kezelésére
JP3468528B2 (ja) ペプチド誘導体
JPS63502106A (ja) 抗原とｔ４リンパ球との相互作用を阻害し得るペプチド及び該ペプチドから誘導された産生物及びそれらの使用
US7122193B1 (en) Retro peptides, antibodies thereto and their uses for vaccination and in vitro diagnosis
KR20020047245A (ko) 면역요법에 사용하기 위한 수정 펩티드 및 펩티드모방체
US6683048B1 (en) Compounds and methods for stimulating gene expression and cellular differentiation
Maillère et al. Fine chemical modifications at N-and C-termini enhance peptide presentation to T cells, by increasing the lifespan of both free and MHC-complexed peptides
US6825319B1 (en) Synthetic peptides and pharmaceutical compositions comprising them for diagnosis and treatment of anti-phospholipid syndrome
AU2002339227A1 (en) Triple polypeptide complexes
US6423315B1 (en) Synthetic peptide for treatment of autoimmune arthritis
JPH11507620A (ja) 合成ペプチドおよびそれらを含有する医薬組成物
JP2001511143A (ja) コラーゲン▲ｉｉ▼に特異的なｔ細胞エピトープを含むペプチド
JP2002521388A (ja) 自己免疫疾患の免疫療法に使用するための新規ペプチド
JPS62501502A (ja) 免疫調節性ペプチド
Skarlas et al. HLA‐DQ7 β1 and β2 derived peptides as immunomodulators
RU2177803C1 (ru) Средство, обладающее иммуностимулирующей активностью
BROCKE c. 3 HLA-OO/H2-0 in antigen presentation

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid